Adherencia Terapeutica Dra Eva Lopez Gonzalez

Introduction to Therapeutic Adherence

Definition and Importance

• Dr. Eva López González introduces the concept of therapeutic adherence, defined by the World Health Organization in 2003 as a person's behavior in taking medication, following dietary plans, and making lifestyle changes according to health provider recommendations.

• Emphasizes the importance of agreeing on treatment plans with patients within a person-centered care model, which includes lifestyle changes, medication adherence, and attending scheduled consultations.

Current Challenges

• Highlights that achieving therapeutic adherence is a significant challenge globally, particularly for chronic diseases where non-adherence rates are alarmingly high.

• Reports that nearly 50% of individuals with non-communicable chronic diseases like diabetes do not adhere to prescribed therapies, leading to increased healthcare costs.

Consequences of Non-Adherence

Impact on Health Outcomes

• Cites a study from 2013 estimating that 125,000 deaths annually in the U.S. are due to non-adherence; up to 70% of hospital admissions may be related to this issue.

• Discusses how low adherence leads to poorer therapeutic outcomes and higher healthcare utilization costs.

Economic Implications

• Notes that addressing adherence can significantly reduce healthcare expenses; for instance, every dollar spent improving adherence could lower costs substantially for diabetic patients.

Factors Influencing Adherence

Dimensions Affecting Adherence

• The WHO identifies several dimensions influencing adherence: healthcare systems and teams' factors, patient-related factors (like socioeconomic status), treatment complexity, and disease-related factors.

Barriers Identified

• Points out barriers such as lack of knowledge among healthcare professionals about strategies to improve adherence and inadequate health services aligned with chronic disease management models.

Patient-Centric Considerations

Disease Complexity

• Discusses how disease progression speed and severity impact patient adherence; those with multiple comorbidities tend to have lower adherence rates.

Treatment Experience

• Addresses how previous treatment failures or adverse effects can lead patients to distrust medications or discontinue them prematurely.

Socioeconomic Factors

Access Issues

• Examines how socioeconomic status affects access to treatments; individuals from lower socioeconomic backgrounds often show poorer adherence both pharmacologically and behaviorally.

Educational Influence

• Stresses that lower educational levels correlate with reduced treatment compliance and unhealthy lifestyle choices.

Strategies for Improving Adherence

Evaluation Techniques

• Suggest methods for evaluating patient adherence through SMART goals—specific, measurable, achievable, relevant, time-bound—to empower patients in their self-management efforts.

Monitoring Methods

• Describes various methods for assessing medication compliance including direct measures (blood tests), indirect measures (pill counts), and subjective assessments via surveys like the Morisky Green test.

Enhancing Communication

Effective Communication Strategies

• Advocates for clear communication regarding medication instructions; emphasizes using legible writing when providing prescriptions or instructions.

Family Involvement

• Encourages involving family members in supporting patients’ treatment regimens by organizing medications into pill organizers or helping set reminders.

Addressing Emotional Barriers

Mental Health Considerations

• Highlights the need for screening tools for depression or anxiety among diabetic patients since these conditions can significantly hinder treatment compliance.

Conclusion: Moving Forward

• Concludes by emphasizing that effective strategies must include informed patient education alongside integrated health system approaches focused on chronic disease management.